Sunshine Biopharma Inc
NASDAQ:SBFM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sunshine Biopharma Inc
NASDAQ:SBFM
|
CA |
|
P
|
Pennant Group Inc
NASDAQ:PNTG
|
US |
|
T
|
TCR2 Therapeutics Inc
F:2K7
|
US |
|
Ampco-Pittsburgh Corp
NYSE:AP
|
US |
Wall Street
Price Targets
SBFM Price Targets Summary
Sunshine Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
SBFM
is 6.12 USD
with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SBFM's stock price target?
Price Target
6.12
USD
According to Wall Street analysts, the average 1-year price target for
SBFM
is 6.12 USD
with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
What is Sunshine Biopharma Inc's Revenue forecast?
Projected CAGR
40%
The
compound annual growth rate
of
Sunshine Biopharma Inc's revenue for the next 1 year is
40%.